Stay updated on REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page. No other study content or functionality changes are evident.
    Difference
    0.1%
    Check dated 2026-01-14T07:25:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Florida listed as a location, and removed the Florida Locations reference. The revision note was updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.2%
    Check dated 2025-12-23T22:31:41.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:37:23.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The funding-status warning about government delays has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:14:51.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Results for NCT03515629 have been posted, including updates to primary and secondary outcomes and the overall study status. The primary endpoint PFS is noted as not assessed due to insufficient data, with other outcomes outlined.
    Difference
    0.4%
    Check dated 2025-11-03T21:21:32.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Major update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.
    Difference
    4%
    Check dated 2025-10-06T05:56:43.000Z thumbnail image

Stay in the know with updates to REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page.